SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artÝculo

LECORNET, Emilie; AHMED, Hashim Uddin; MOORE, Caroline  y  EMBERTON, Mark. Terapia focal en cáncer de próstata: una potencial estrategia para solucionar el problema del sobretratamiento. Arch. Esp. Urol. [online]. 2010, vol.63, n.10, pp.845-852. ISSN 0004-0614.

    1. Marberger M, et al. New treatments for localized prostate cancer. Urol, 2008; 72(6 Suppl): S36-43. [ Links ]

    *2. Ahmed HU, et al. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol, 2007; 4(11):632-42. [ Links ]

    3. Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol, 2005; 23(32): 8165-9. [ Links ]

    4. Zhou P, et al. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol, 2005; 23(28): 6992-8. [ Links ]

    5. Ahmed HU and Emberton M. Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way? World J Urol, 2008; 26(5): 457-67. [ Links ]

    6. Amin M, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl, 2005; (216): 20-33. [ Links ]

    7. Antunes AA, et al. The percentage of positive biopsy cores as a predictor of disease recurrence in patients with prostate cancer treated with radical prostatectomy. BJU Int, 2005; 96(9): 1258-63. [ Links ]

    8. Freedland SJ, et al. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. J Urol, 2003; 169(6): 2136-41. [ Links ]

    9. Polascik TJ and Mouraviev V. Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients. Urol, 2009; 74(4): 726-30. [ Links ]

    10. Bacon CG, et al. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol, 2001; 166(5): 1804-10. [ Links ]

    11. Galbraith ME, Ramirez JM, and Pedro LW. Quality of life, health outcomes, and identity for patients with prostate cancer in five different treatment groups. Oncol Nurs Forum, 2001; 28(3): 551-60. [ Links ]

    12. Litwin MS, et al. Mental health in men treated for early stage prostate carcinoma: a posttreatment, longitudinal quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. Cancer, 2002; 95(1): 54-60. [ Links ]

    13. Lindner U and Trachtenberg J. Focal therapy for localized prostate cancer -choosing the middle ground. Can Urol Assoc J, 2009; 3(4): 333-335. [ Links ]

    14. Latini DM, et al. The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol, 2007; 178(3 Pt 1): p. 826-31; discussion 831-2. [ Links ]

    15. Dale W, et al. The role of anxiety in prostate carcinoma: a structured review of the literature. Cancer, 2005; 104(3): 467-78. [ Links ]

    16. Pickles T, et al. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU Int, 2007; 100(3): 544-51. [ Links ]

    17. Burnet KL, et al. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int, 2007; 100(3): 540-3. [ Links ]

    *18. Klotz L. Active surveillance with selective delayed intervention for favorable risk prostate cancer. Urol Oncol, 2006; 24(1): 46-50. [ Links ]

    19. Black P. There is no role for focal therapy in prostate cancer. Can Urol Assoc J, 2009; 3(4): 331-332. [ Links ]

    *20. Johansson JE, et al. Natural history of early, localized prostate cancer. JAMA, 2004; 291(22): 2713-9. [ Links ]

    21. Jayram G and Eggener SE. Patient selection for focal therapy of localized prostate cancer. Curr Opin Urol, 2009; 19(3): 268-73. [ Links ]

    22. Hu JC, et al. Patterns of care for radical prostatectomy in the United States from 2003 to 2005. J Urol, 2008; 180(5): 1969-74. [ Links ]

    23. Thuroff S, et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol, 2003; 17(8): 673-7. [ Links ]

    24. Blana A, et al. Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer. Urol, 2008; 72(6): 1329-33; discussion 1333-4. [ Links ]

    25. Ahmed HU, Moore C, and Emberton M. Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol, 2009; 18(3): 219-32. [ Links ]

    26. Ritch CR and Katz AE. Prostate cryotherapy: current status. Curr Opin Urol, 2009; 19(2): 177-81. [ Links ]

    *27. Onik G. Rationale for a "male lumpectomy", a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up. Cardiovasc Intervent Radiol, 2008; 31(1): 98-106. [ Links ]

    28. Onik G, et al. The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol, 2008; 26(5): 500-5. [ Links ]

    *29. Bahn DK, et al. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol, 2006; 20(9): 688-92. [ Links ]

    30. Ellis DS, Manny TB, and Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urol, 2007; 70(6 Suppl): 9-15. [ Links ]

    31. Lambert EH, et al. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology, 2007; 69(6): 1117-20. [ Links ]

    32. Ritch CR and Katz AE. Update on cryotherapy for localized prostate cancer. Curr Urol Rep, 2009; 10(3): 206-11. [ Links ]

    33. Emberton M. VTP for men with prostate cancer - Early Results. J Endourol, 2008; 22: 3. [ Links ]

    34. Tareen B, et al. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int, 2009; 104(2): 195-9. [ Links ]

    35. Sartor AO, et al. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urol, 2008: 72(6 Suppl): S12-24. [ Links ]

    36. Bostwick DG, et al. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urol, 2007; 70(6 Suppl): 42-4. [ Links ]

    *37. Onik G and Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol, 2008; 26(5): 506-10. [ Links ]

    38. Tsivian M, et al. Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended. BJU Int, 2009. [ Links ]

    *39. Crawford ED, et al. Clinical staging of prostate cancer: a computer-simulated study of transperineal prostate biopsy. BJU Int, 2005; 96(7): 999-1004. [ Links ]

    40. Turpen R and Rosser CJ. Focal therapy for prostate cancer: revolution or evolution? BMC Urol, 2009; 9: 2. [ Links ]

    41. Barzell WE and Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: the role of transperineal 3-dimensional pathologic mapping of the prostate-a 4-year experience. Urol, 2007; 70(6 Suppl): 27-35. [ Links ]

    42. Turkbey B, et al. Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol, 2009; 192(6): 1471-80. [ Links ]

    *43. Turkbey B, Pinto PA, and Choyke PL. Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol, 2009; 6(4): 191-203. [ Links ]

    44. Yang JC, et al. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels. Acad Radiol, 2008; 15(10): 1291-7. [ Links ]

    45. Tang J, et al. Peripheral zone hypoechoic lesions of the prostate: evaluation with contrast-enhanced gray scale transrectal ultrasonography. J Ultrasound Med, 2007; 26(12): 1671-9. [ Links ]

    46. Halpern EJ, et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer, 2005; 104(11): 2373-83. [ Links ]

    47. Braeckman J, et al. Computer-aided ultrasonography (HistoScanning): a novel technology for locating and characterizing prostate cancer. BJU Int, 2008; 101(3): 293-8. [ Links ]

    48. Braeckman J, et al. The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int, 2008; 102(11): 1560-5. [ Links ]

    49. Ahmed HU, et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol, 2009; 6(4): 197-206. [ Links ]

    50. Krieger A, et al. Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng, 2005; 52(2): 306-13. [ Links ]

    51. Atri M, et al, Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. Can Urol Assoc J, 2009; 3(2): 125-30. [ Links ]

    *52. Lindner U, et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol, 2009; 182(4): 1371-7. [ Links ]

    53. McNichols RJ, et al. MR thermometry-based feedback control of laser interstitial thermal therapy at 980 nm. Lasers Surg Med, 2004; 34(1): 48-55. [ Links ]

    54. de Senneville BD, Mougenot C, and Moonen CT. Real-time adaptive methods for treatment of mobile organs by MRI-controlled high-intensity focused ultrasound. Magn Reson Med, 2007; 57(2): 319-30. [ Links ]

    55. de Senneville BD, et al. MR thermometry for monitoring tumor ablation. Eur Radiol, 2007; 17(9): 2401-10. [ Links ]

    56. Mougenot C, et al. Three-dimensional spatial and temporal temperature control with MR thermometry-guided focused ultrasound (MRgHIFU). Magn Reson Med, 2009; 61(3): 603-14. [ Links ]

    57. Mouraviev V, et al. Analysis of laterality and percentage of tumor involvement in 1386 prostatectomized specimens for selection of unilateral focal cryotherapy. Technol Cancer Res Treat, 2007; 6(2): 91-5. [ Links ]

    58. Mouraviev V, Polascik TJ, Pathological background and its clinical implications for focal therapy of early detected prostate cancer. Nat Clin Pract Urol., in press. [ Links ]

    59. Mouraviev V, et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer, 2007; 110(4): 906-10. [ Links ]

    60. Tareen B, et al. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort. Urol, 2009; 73(2): 351-4; discussion 354-5. [ Links ]

    61. De Laet K, et al. Predicting tumour location in radical prostatectomy specimens: same-patient comparisons of 21-sample versus sextant biopsy. BJU Int, 2009; 104(5): 616-20. [ Links ]

    62. Villers A, et al. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance. Curr Opin Urol, 2009; 19(3): 274-82. [ Links ]

    63. Nelson BA, et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int, 2006; 97(6): 1169-72. [ Links ]

    64. Villers A, et al. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer, 1992; 70(9): 2313-8. [ Links ]

    65. Iczkowski KA, et al. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urol, 2008; 71(6):1166-71. [ Links ]

    66. Noguchi M, et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol, 2003; 170(2 Pt 1): 459-63. [ Links ]

    67. Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med, 2009; 361(17): 1704-6. [ Links ]

    68. Eggener SE, et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol, 2007; 178(6): 2260-7. [ Links ]